News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
High School Students "Punched" Martin Shkreli in the Face by Recreating $750 HIV Pill for a Mere $2     12/2/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
GlaxoSmithKline (GSK) Execs Set High Hopes for Game-Changing HIV Research Strategy     8/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Theratechnologies (TH.TO) Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial     5/24/2016
FDA Approves Gilead (GILD)'s Next-Generation HIV Drug Descovy     4/5/2016
FDA Green Lights Gilead (GILD)’s Odefsey to Treat HIV-1 Infection in Certain Patients     3/2/2016
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015

News from Around the Web
Needle Exchanges, Once Met With Fierce Resistance, Are Working     12/6/2016
Why Can't We Bring Down The Number Of New HIV Cases?     12/1/2016
Injections, Implants Tested As New Weapons To Prevent HIV     11/30/2016
Experimental Vaginal Ring Fights HIV, But Will Women Wear It?     11/16/2016
Imperial College London Scientists Develop New Type Of HIV Test On A USB Stick     11/10/2016
Magic Johnson's HIV Story Offers Hope For Cancer Patients     11/8/2016
HIV Vaccine A Step Closer, The Scripps Research Institute Study     9/13/2016
Is There Anyone The Drug Industry Hates More Than This AIDS Activist?     9/6/2016
First Next-Generation Sequencing Test For HIV Drug Resistance Could Help Combat AIDS Worldwide, Vela Diagnostics Reveals     8/4/2016
A Different Way To Test For HIV Or Allergens, University of Florida Study     7/26/2016
Vaginal Ring May Cut HIV Infection Risk If Used Consistently, NIAID Study     7/19/2016
Drugs That Saved HIV Patients Now Threaten Them In Old Age     7/6/2016
Startup Targets HIV Drug Resistance In Developing Countries, Aldatu Biosciences Reveals     6/16/2016
In Pursuit Of An HIV Vaccine And The AIDS-Free Generation     5/17/2016
First Liver Transplant Between HIV-Positive Donor And Recipient Marks Milestone For HIV Patients, Johns Hopkins University Reveals     3/31/2016

Press Releases
Sorrento (SRNE) Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido     12/5/2016
bioLytical™ Laboratories Introduces INSTI HIV Self Test To Kenyan Regulated Pharmacy Network     12/2/2016
bioLytical™ Laboratories Launches INSTI HIV Self Test For African Market In Response To New WHO Guidelines     12/2/2016
YiSheng BioPharma To Collaborate With The Scripps Research Institute On AIDS Vaccine     11/8/2016
Theratechnologies (TH.TO) Release: Results Of HIV Biologic And Long-Acting Investigational Antiretroviral Ibalizumab To Be Presented In Late-Breaker Session At IDWeek 2016     10/28/2016
Atomo Diagnostics Receives Grant To Develop New, Innovative HIV Self-Test Solution     10/27/2016
Gilead (GILD) Touts 2-Year Late-Stage Descovy-Truvada HIV Data     10/24/2016
CytoDyn (CYDY) Files Protocol For Extended Access To PRO 140 For Patients Who Reach The End Of PRO 140 Pivotal Phase III Trial     10/24/2016
Gilead (GILD) Asks FDA To Expand Exclusivity For A Key HIV Drug     10/21/2016
ExeGi Pharma Release: High Concentration Probiotic May Reduce Gastrointestinal And Neurological Inflammation In HIV Patients     10/21/2016
New amfAR Grants Support Next Generation Of Scientists Pursuing Innovative Solutions To HIV/AIDS     10/21/2016
amfAR Publishes Recommendations For Health Plans And Health Care Purchasers To Support Efforts To Curb The HIV Epidemic In The U.S.     10/14/2016
Napo Pharmaceuticals, Inc. Launches Mytesi (Crofelemer) As The Only FDA-Approved Treatment For Relief Of Noninfectious Diarrhea In HIV+ Patients     10/13/2016
University Of Natural Resources And Life Sciences Release: Hidden HIV Revealed: New Insights Into Latent HIV Infections     9/26/2016
Selexis SA And IAVI Expand Collaboration To Advance Multiple HIV Vaccine Candidates Toward Clinical Testing     9/22/2016

//-->